Skip to main content
Market intelligence
ADMAHealthcare

Adma Biologics Inc insider activity

In the last 90 days, 1 corporate insider purchased $250,874 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$250,874
Corporate buyers
1
Latest transaction
May 27, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
May 27, 2026Jerrold B GrossmanDirectorOpen Market Purchase6,400$7.91$50,624
May 12, 2026Jerrold B GrossmanDirectorOpen Market Purchase12,500$8.01$100,125
May 11, 2026Jerrold B GrossmanDirectorOpen Market Purchase12,500$8.01$100,125